My Account
Log in Registration
All
Cart
Highlights
Fiction Books
Non-Fiction Books
Children's Books
Rare Books
Music
DVD & Blu-Ray
Video Games
Category
Wishlists
Cart
All
Free US shipping over $10
Trustpilot
Proud to be B-Corp

Pathophysiology, Pharmacology and Biochemistry of Dyskinesia Volume editor Jonathan Brotchie

Pathophysiology, Pharmacology and Biochemistry of Dyskinesia By Volume editor Jonathan Brotchie

Pathophysiology, Pharmacology and Biochemistry of Dyskinesia by Volume editor Jonathan Brotchie

Reviews:
$239.19
Condition - New
Only 2 left
New

Summary

Reviews theories and research surrounding the movement disorder Dyskinesia. This title reviews state-of-the-art in their field of investigation and provides their views and perspectives for future research. It provides readers with a comprehensive list of resources on the topics covered.

Pathophysiology, Pharmacology and Biochemistry of Dyskinesia Summary

Pathophysiology, Pharmacology and Biochemistry of Dyskinesia: Volume 98 by Volume editor Jonathan Brotchie

Published since 1959, International Review of Neurobiology is a well-known series appealing to neuroscientists, clinicians, psychologists, physiologists, and pharmacologists. Led by an internationally renowned editorial board, this important serial publishes both eclectic volumes made up of timely reviews and thematic volumes that focus on recent progress in a specific area of neurobiology research. This volume reviews existing theories and current research surrounding the movement disorder Dyskinesia.

Pathophysiology, Pharmacology and Biochemistry of Dyskinesia Reviews

"Invaluable reading." --NATURE "A valuable addition to any library as current reference material for advanced undergraduates, graduate students, and professional scientists." --CHOICE

About Volume editor Jonathan Brotchie

Professor Peter Jenner is a specialist in preclinical aspects of neurodegenerative diseases, notably Parkinsons disease. He has spent the major part of his career at Kings College London where he was Head of Pharmacology for 14 years before returning to his research roots and subsequently becoming Emeritus Professor of Pharmacology. Peter has expertise in drug metabolism and pharmacokinetics but neuropharmacology based on functional models of neurodegenerative diseases has formed the major focus of his work. Peter holds a BPharm, PhD and DSc degree from the University of London. He has published well over 1000 articles with more than 700 peer reviewed papers. He is a Fellow of the Royal Pharmaceutical Society, the British Pharmacological Society, the Royal Society of Medicine and of Kings College London. Peter was recently honoured with a Doctor Honoris Causa degree from Carol Davila University of Medicine and Pharmacy, Bucharest and made an Honorary Fellow of The British Pharmacological Society for his contribution to research in to movement disorders. Peter has worked closely with the pharmaceutical industry for many years and acts as an adviser and consultant to both major pharma and biotech companies. He has a wide knowledge of the drug discovery and drug development process and has been involved from molecule synthesis through to drug registration for use in man. Peter was the Founder, Director and Chief Scientific Officer of Proximagen, a biotech focussed on the treatment and cure of neurodegenerative diseases that was listed on AIMs and subsequently purchased by a US based healthcare company. He is a regular speaker at international meetings and also takes time to speak at Parkinsons disease patient-carer groups across the UK.

Table of Contents

An introduction to dyskinesia - the clinical spectrum Joseph Jankovic and Ainhia Ha L-dopa induced dyskinesia clinical presentation, genetics and treatment Wassilios Meissner and Sue Fox Experimental models of LID Emma Lane and Tom Johnston Mechanisms underlying LID Gilberto Fisone Novel approaches to therapy Jonathan Brotchie Surgical approaches to LID Andres Lozano Tardive dyskinesia clinical presentation and treatment Peter van Harten Epidemiology and risk factors for TD Diederik Tenback Genetics of TD Heon-Jeong Lee Experimental models of TD S.K. Kulkarni Surgical approaches to TD Philippe Damier Huntingtons chorea clinical presentation and treatment Sarah J Tabrizi Genetics and pathology of HD Anton Reiner Pathogenic mechanisms in HD Lesley Jones Experimental models of HD and novel therapeutic approaches RJ Ferrante Robert J. Ferrante Cell based treatments for HD Stephen Dunnett Clinical phenomenology of dystonia A. Beradelli Genetics and pharmacological treatment of dystonia Susan Bressman Experimental models of dystonia Antonio Pisani Surgical treatment of dystonia Tipu Aziz

Additional information

NPB9780123813282
9780123813282
012381328X
Pathophysiology, Pharmacology and Biochemistry of Dyskinesia: Volume 98 by Volume editor Jonathan Brotchie
Volume editor Jonathan Brotchie
New
Hardback
Elsevier Science Publishing Co Inc
2011-11-02
664
N/A
Book picture is for illustrative purposes only, actual binding, cover or edition may vary.
This is a new book - be the first to read this copy. With untouched pages and a perfect binding, your brand new copy is ready to be opened for the first time

Customer Reviews - Pathophysiology, Pharmacology and Biochemistry of Dyskinesia